INTRODUCTION:

The Orchidaceae family is one of the most diverse and advanced evolutionary groups in the plant kingdom. It consists of more than 30,000 species that have great ornamental, ecological, and medicinal importance¹. Apart from their ornamental value, orchids have been significant in the traditional medicine of cultures around the world for thousands of years and are documented in the ancient records of Sumerian, Ayurvedic, and Chinese medicine². The Acampe genus, a group of monopodial epiphytic orchids native to tropical Africa and Asia, is a hidden but underutilized reservoir of this bio-cultural resource. Among the species, Acampe papillosa (Lindl.) Lindl. It is of particular importance to the study of orchids due to its botanical normalcy and the increasing acknowledgement of its therapeutic characteristics.

A. papillosa displays very strong, evergreen, tufted leaves and inflorescences that have multiple pendulous racemes of yellow-green flowers. A. papillosa has been used for its aesthetic appeal ³. However, like many other members of the orchid family, A. papillosa's natural populations are declining very rapidly due to habitat destruction and collection for horticultural and traditional medicine. There is a clear need for research and conservation ⁴. The species has ornamental appeal ⁵, but it also has a long history of use in traditional medicine. Ethnobotanical references documented in the local tradition indicate that the roots of A. papillosa are used for treating rheumatism, as well as other plants in the genus, which have local use as poultices for broken bones, such as Acampe praemorsa, by communities in the Eastern Ghats of India ⁶.

A significant barrier to the study and application of orchids, such as A. papillosa, is their biology—specifically, their reproductive biology. The seeds of orchids are tiny, lack an endosperm, and harbour an undifferentiated embryo, meaning that germination in nature is obligately reliant on a symbiotic relationship with certain mycorrhizal fungi ⁷. This dependence restricts natural recruitment and makes large-scale propagation impossible. Knudson (1922) was the first to successfully demonstrate asymbiotic germination in vitro on sugar-based media, which contributed to the foundation for conservation and biotechnological applications. Asymbiotic germination protocols with immature embryos have been developed for A. papillosa, and the Mitra (M) medium supplemented with coconut water (15%) supported the highest rates of germination and seedling development ⁸. In vitro methods for the germination of orchids can contribute to mass propagation, conservation of genetic materials, and a sustainable source of plants for future phytochemical and pharmacological studies.

Plants are known to possess a range of medicinal properties, mainly due to their plentiful and diverse array of secondary metabolites. There are only a couple of phytochemical studies on A. papillosa, but concepts from related species in the Acampe genus, specifically A. praemorsa, can be supported with data from A. papillosa. A. praemorsa has previously demonstrated bioactive constituents that include the phenanthropyran compound, Praemorsin, as well as various alkaloids, flavonoids, glycosides, and terpenoids, oftentimes correlated with antimicrobial, anti-inflammatory, and antioxidant effects ^9,10. Moreover, studies on other orchids belonging to the Acampe genus, and even the family Orchidaceae, have reported significant antimicrobial activity against multiple gram-positive and gram-negative bacteria, along with reported anti-fungal activity ¹¹. The extracts of orchids usually yield the most significant activity when utilizing ethyl acetate and methanol, which indicates medium-polarity bioactive compounds may be present. Or perhaps even more importantly, many orchids are now being studied for anticancer activity. For example, Aeridis odarata (syn. Aerides odorata), another epiphytic orchid species, has been found to have significant in vitro cytotoxic activity against breast cancer (MCF-7) and cervical cancer (HeLa) cell lines, and methanolic extracts also have favorable IC₅₀ values ¹². The growing evidence suggests that A. papillosa, with a similar phytogenetic and ecological niche, may also contain useful therapeutic compounds worth investigating.

Botanical description and Phytochemical constituents:

Taxonomical classification: Acampe papillosa is a member of the large, diversified Orchidaceae family of flowering plants. Its taxonomic hierarchy is stated as follows¹³:

· Kingdom: Plantae

· Clade: Tracheophytes

· Clade: Angiosperms

· Order: Asparagales

· Family: Orchidaceae

· Subfamily: Epidendroideae

· Genus: Acampe

· Species: A. papillosa

Plant habit and morphology: A. papillosa is a perennial, epiphytic orchid species, indicating that it grows on other plants for physical support without being parasitic. Its growth form is considered to be robust and thick ¹⁵.

Stem: The stem is fleshy, stout, cylindrical, and occasionally climbing, achieving a length of 30-50 cm (Natta et al.) with a diameter ranging from 1.0 to 1.6 cm¹⁴. Its stem is cylindrical and green, generating roots from the basal nodes, securing A. papillosa to its support.

Leaves: The leaves are distichous or in two opposite rows, thick, coriaceous, and lorate or strap-shaped, with a terminal unequally bilobed apex. They measure approximately 12-20 cm long and 2-3 cm wide. The leaves are an overall green. A microscopic examination of the stomata indicated an anomocytic type, characterized by guard cells being adjacent to a variable number of cells that are not distinctly different in either size or shape from surrounding epidermal cells ¹⁶.

Inflorescence and Flowers: The inflorescence has a corymbose (flat-topped) shape that is much shorter than the leaves, reaching lengths of about 5-6 cm in height ¹⁷.

Flowers: The flowers are clustered together with 8-12 flowers in each inflorescence. They have a pleasant fragrance and are long-lasting, usually packed tightly together and characterized by a diameter of 1-2 cm. The typical flower color in A. papillosa is yellow, barred or spotted with reddish-brown stripes; however, a unique variety, A. papillosa var. flava, is known from the foothills of Darjeeling and Duars of West Bengal, India, which is described as having vividly yellow sepals and petals with no stripes or spots ¹⁷.

Perianth: The sepals and petals are subequal.

Lip (Labellum): The lip is white and has caruncles (small, fleshy projections) and a sparse speckling of magenta to dark brown spots.

Fruits and seeds: The fruit is a fusiform (spindle-shaped), sub-sessile capsule. Similar to all orchids, the seeds are minute and dust-like, and rely on a symbiotic relationship with mycorrhizal fungi for germination¹⁷.

Microscopic Characteristics: Powder microscopy of the entire plant provides important identification markers for quality control ¹⁸. The powder includes xylem vessels that convey water. Parenchyma cells are present, which serve in storage. Fibres provide structural support. The cellulose cell wall is a basic part of plant cells. Chitin (a polymer contained within the cell wall of fungi) has also been observed, likely related to the endophyte or mycorrhizal fungi in association with the orchids, followed by the roots. Also in the preparation are Trichomes (plant hair). Microchemical testing indicates cellulose, lignin, suberin, cutin, chitin, tannins, starch, and mucilage were present, and proteins and calcium-based crystals (oxalate or carbonate) were absent ¹⁹.

Cultivation and Distribution: A. papillosa is commonly found across India, especially in the North-Eastern Himalayan region, such as Sikkim, Nagaland, Meghalaya, and Kerala. It is also discovered in the Darjeeling foothills, Terai, and Duars of West Bengal (Awasthi et al.; Natta et al.). The plant is versatile and can grow in almost any type of soil; however, it prefers to be cultivated in humid areas, with soil having acidic to neutral pH (pH 6-8), at least 400-500 mm of rainfall annually, and annual temperatures in the range of 19-27 °C ²⁰.

Phytochemical Constituents of Acampe papillosa:

The therapeutic action of A. papillosa is linked to a diverse range of bioactive compounds from the different parts of the plant. Phytochemical investigations with various extraction solvents and methods of analysis have exhibited a wide spectrum of abundance of primary and secondary metabolites from A. papillosa.

Preliminary Phytochemical Screening: Qualitative phytochemical screening of successive extracts of A. papillosa (petroleum ether, chloroform, methanol, and ethanol) gives an overall picture of its chemical makeup²¹

· Petroleum Ether Extract: present fixed oils and fats

· Chloroform Extract: Alkaloids, steroids, and fixed oils are positive

· Methanol Extract: the widest variety of phytochemicals, including alkaloids, glycosides, steroids, tannins, phenols, flavonoids, fixed oils, and mucilage, indicating that methanol is an effective solvent for a broad range of polar and semi-polar bioactive compounds

· Ethanol Extract displays the presence of alkaloids, carbohydrates, tannins, and phenols

Overall, the presence of phenols and flavonoids in the methanolic extract is noteworthy, as these classes of compounds are well-known to display antioxidant and anti-inflammatory activities.

Phenolic Compounds and Flavonoids: Phenolic compounds are an important class of antioxidants in plants. A study by Natta et al. (2022) surveyed six medicinal orchids from the North-Eastern Himalayan region for phytochemical quantities, and their data showed that in A. papillosa, *total phenolic content was the highest among the six samples, with a record value of 4.09 g GAE/100 g, clearly indicative of its potential as an antioxidant.

In addition, A. papillosa in Natta et al. (2022) showed:

Total Flavonoid Content: 17.10 mg QE/100 g.

Total Tannin Content was 3.17 g TAE/100 g, showing the highest tannin present among the six orchids in the study. Tannins are known as anti-parasitic, astringent, and anti-inflammatory.

Total Saponin Content was 7.20 g/100 g, showing the highest saponin present among the six orchids. Saponins are known as cholesterol-binding, hemolytic, and immune-modulating.

HPLC (High Performance Liquid Chromatography) was used to detect and quantify specific phenolic acids and flavonoids, and in A. papillosa, the following phenolic acids and flavonoids were observed ²²:

Caffeic Acid: Quantified in A. papillosa with a remarkable quantification of 224 mg bulk sample. Caffeic acid is known for its antioxidant and anti-inflammatory activity.

Additionally, other phenolic compounds, including quercetin, catechin, and sinapic acid, were found, but at lower levels than some of the Dendrobium species in the same study.

Alkaloids: Alkaloids are nitrogenous compounds that exhibit various pharmacological effects. Total alkaloid concentrations in A. papillosa were found to be 10.7 g/100 g ²³, which is considered considerable when comparing other orchids. Specific alkaloids identified in A. papillosa were not mentioned in the given studies; however, the genus Acampe and the orchidaceae family are known to have different alkaloids.

Volatile and Lipophilic Compounds (GC-MS Study): Gas Chromatography-Mass Spectrometry (GC-MS) is an excellent approach for profiling volatile and lipophilic compounds, as well as their non-volatile counterparts. Natta et al. performed GC-MS on methanolic extracts of A. papillosa and reported the identification of some important bioactive metabolites. Examples of bioactive metabolites found include:

Methyl (methylthio) disulfide: Identified in A. papillosa, this organosulfur compound can be considered a regional biomarker for the species. Organosulfur compounds have well-studied antioxidant and antimicrobial properties.

Spiro [3.5] nonan-1-one, 5-methyl-, trans: A secondary metabolite produced in plants in response to (UV) radiation stress, indicating the presence of a stress response compound that contains possible protective biological activities. A total of 26 bioactive compounds across the six orchid species were identified in the GC-MS study, with A. papillosa providing a unique compound.

Fatty Acids and Other Constituents: The papers reviewed above primarily focus on A. papillosa, but an odd phytochemistry section (Awasthi et al.) appears to confuse A. papillosa with a different plant (e.g., invoking Mucuna pruriens compounds such as L-DOPA). Disregard that particular information for A. papillosa altogether; however, preliminary screening detected fixed oils, leading to the conclusion that A. papillosa contains fatty acids. Fatty acids commonly employed in plants are palmitic, stearic, oleic, and linoleic acids, but further targeted analyses will be needed to consider the profile of fatty acids in A. papillosa.

Nutritional and Mineral Composition: The paper by Natta et al. also substantiated valuable data regarding nutritional analysis of A. papillosa, addressing the following data points:

Moisture Content: The moisture content of A. papillosa was relatively low, resulting in a high content of dry matter; this is beneficial for the dried plant material used in applications to medicines.

Total Carbohydrates and Proteins: The levels of carbohydrates and soluble proteins in A. papillosa were lower than some proven Dendrobium species levels, but still serve as a carbohydrate and protein source for energy.

Acampe papillosa is a promising orchid that boasts a diverse phytochemical profile, characterized by the significant presence of phenolic compounds, tannins, saponins, and alkaloids. Modern chromatographic techniques are now being used to isolate some of the more common bioactive molecules, such as caffeic acid and some rare compounds containing sulfur. The wealth of all plant bioactive phytochemicals provides support for its traditional use for many ailments, such as rheumatism, arthritis, pain, and infections. Testing of the methanol extract has shown it to be the most effective in extracting numerous bioactive constituents. Studying the chemical composition of Acampe papillosa, including the isolation and characterization of bioactive compounds, especially the unique alkaloids and volatile constituents, is critical to understanding its mechanism of action and creating a standardized herbal formulation²⁴.

Traditional uses:

The ethnomedicinal uses of Acampe papillosa are incredibly varied, spanning multiple physiological systems. The sub-sections below are organized by the conditions it has been documented to treat:

Musculoskeletal and pain conditions: One of the most consistent uses of A. papillosa is for pain and inflammatory conditions of the musculoskeletal system. Across A. papillosa geographic range, tribal peoples prepare a paste from the roots, which is then applied topically to relieve symptoms.

Rheumatism and arthritis: The root paste is often used to reduce joint inflammation, pain, and stiffness associated with rheumatism and arthritis ²⁵.

Backache and trauma pain: The plant's analgesic properties are utilized by applying the paste or juice to the affected location to reduce pain associated with backaches and pain resulting from physical trauma ²⁶.

Bone fractures: While the use of pastes with orhids as a plaster mixed with other ingredients (e.g., egg white) for fractured bones, is more commonly documented for a relative of Acampe praemorsa, this is a known practice for several tribes ²⁶. Thus, it is possible that A. papillosa is used for the same purpose in some communities, specifically as it is thought to heal bones.

Gynecological and Abdominal Problems: A. Papillosa is used by traditional practitioners to address a range of female-specific problems and general abdominal disorders.

Dysmenorrhea: The root in paste form or juiced is prescribed for the reduction of cramps and pain associated with menstruation²⁷.

Uterine Issues: It is also indicated for the treatment of unspecified uterine problems, demonstrating its role in women's health ^27,28.

Stomach Issues: External application and internal consumption of the leaf juice are used to treat stomach aches. In some cases, leaf juice is applied over the nipple in infants for stomach cramps ³⁰.

Neurological and Fever: The plant is also recognized for its activity on the nervous system and its ability to reduce fever.

Neuralgia: Traditional preparations are also used to treat nerve pain (neuralgia), suggesting neuropharmacological activity ²⁷.

Fever / Headaches: Paste made from the plant is

thought to effectively reduce fever and headaches ³¹. It is also used to help regulate body temperature ²⁸.

Dermatological and Anti-infective Uses: The topical application of A. papillosa extracts toward dermatological conditions and infectious processes has demonstrated both antimicrobial and wound healing properties.

Burns: The paste is used for application onto burns to aid healing and to prevent infection²⁹.

Syphilis: The paste has been used traditionally to treat syphilis, a bacterial sexually transmitted infection³¹.

Poisonous Infections and Snake Bites: It is perhaps one of the most important traditional uses to treat poisonous infections like snake bites. The root paste is applied directly to the site in these cases, as part of the first-line treatment³⁰. This is consistent in other Acampe species, which are also utilized for scorpion stings and snake bites ³¹.

Pharmacological Activity:

The potential medical use of Acampe papillosa, as derived from its long-standing traditional uses, is reinforced by increasing scientific evidence showing several pharmacological activities, which can be largely attributed to its rich and diverse phytochemical profile, particularly phenolics, flavonoids, tannins, saponins, and other bioactive metabolites.

1. Antioxidant activity: -Oxidative stress through an imbalance of reactive oxygen species (ROS) to bodily antioxidant defences has been implicated in the pathogenesis of many chronic diseases. The antioxidant activity of A. papillosa is notable as one of the most potent pharmacological characteristics of the herb, providing scientific evidence for its use in inflammatory and degenerative conditions³².

A detailed phytochemical assessment revealed A. papillosa to have a more prominent total phenol content (4.09 g GAE/100g) than any of the other six medicinal orchid species tested, which included selections from the Dendrobium genus as well. Phenolic compounds are particularly well known for their redox capabilities that facilitate hydrogen donation, quench singlet oxygen, and chelate metals (Suman Natta). The study also showed strong positive correlations between total phenol content and free radical scavenging activity. Notably, the methanolic extract of A. papillosa generated significant scavenging activity against the 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS) radical with an IC₅₀ value of 131.02 µg/ml. With its noteworthy antioxidant properties, A. papillosa may represent an attractive natural source of compounds that inhibit oxidative damage related to aging, arthritis, and neurological deficiencies³⁵.

Though the specific research on oxidative stress was performed on its close relative Acampe praemorsa, the results are very applicable. The results of the study indicated that hydroalcoholic extracts had a strong antioxidant activity both in vitro and in vivo by increasing levels of endogenous antioxidants like superoxide dismutase (SOD) and catalase, and reducing the lipid peroxidation as noted by malondialdehyde (MDA). Given the similar phytochemistry in A. papillosa, it is likely that it has similarly strong antioxidant action³².

2. Antimicrobial Activity: - The historic use of A. papillosa paste and juices for the treatment of wounds, infections, and snake bites would indicate that it could also have some form of inherent antimicrobial activity. There was not a specific antimicrobial assay for A. papillosa in the provided documents, but studies on the close relative, Acampe praemorsa, provide strong supporting data ³³.

Research for A. praemorsa was done on the ethyl acetate extract and showed relevant antibacterial and antifungal activity. Specifically, the extract had a zone of inhibition of 17 mm against Candida albicans, indicating moderate antifungal activity. Additionally, the extract showed broad-spectrum activity against multiple Gram-positive and Gram-negative bacterial strains. The association of these results with the phytochemical evaluation of A. papillosa, which revealed high levels of tannins (3.17 g TAE/100g) and saponins (7.20 g/100g), supports the potential mechanism for its antimicrobial use (Jhansi K). Tannins can inactivate microbial adhesins, enzymes, and cell envelope transport proteins, and saponins display antimicrobial activity by disrupting fungal and bacterial cell membranes ³³.

3. Cytotoxic and Potential Anticancer Activity: - The discovery of novel bioactive compounds in A. papillosa through GC-MS analysis supports its potential in cancer treatment. Although specific cytotoxic studies on A. papillosa are required, the proven presence of medicinally relevant volatile compounds warrants further investigation. The ethnopharmacological reports of use against tumors in related species, such as Aeridis odarata, and the in vitro cytotoxicity reports on its extract against MCF-7 breast cancer (IC₅₀ of 26.21 µg/ml) support the rationale that these orchids may have anticancer activity within this tribe³⁴. Such activity was documented and is generally attributed to alkaloids, as well as phenanthrene derivatives known for their ability to interfere with intracellular proliferation and apoptosis pathways³⁵.

4. Anti-inflammatory and Analgesic Potential: - The historical use for the treatment of rheumatism, arthritis, backache, and neuralgia associated with A. papillosa is certainly suggestive of potent anti-inflammatory and analgesic effects (Suman Natta). The presence of significant levels of anti-inflammatory phytochemicals, including flavonoids, tannins, and phenolics, further supports this use³⁵. Flavonoids can inhibit several significant enzymes involved in inflammation, specifically cyclooxygenase (COX) and lipoxygenase (LOX), and reduce the formation of prostaglandins and leukotrienes. Tannins have been shown to have anti-inflammatory and anti-ulcer effects in rodent studies. The antiplatelet aggregation activity recorded in other medicinal orchids, such as the Dendrobium species (due to the presence of phenanthrene), may also be relevant, as inflammation and platelet aggregation are often linked³⁴.

5. Other Potential Activities: - Phytochemical studies found other compounds of particular biological activity. For example, the identification of compounds such as methyl (methylthio) disulfide in A. papillosa suggests a possible biomarker or specific biocidal activity. Additionally, the high mineral content of A. papillosa, particularly zinc, iron, and manganese (because they serve as cofactors for antioxidant enzymes), can enhance the overall therapeutic effect of medicinally important biochemical processes³⁴.

Conservative status and challenges:

Similar to many epiphytic and lithophytic orchids, Acampe papillosa is under a variety of anthropogenic and ecological pressures, endangering natural populations. Primary threats include habitat loss and fragmentation as a result of agricultural activity, mining, clearing of forests for fuelwood and timber, and converting forested slopes into plantations. Since A. papillosa typically associates with niche microhabitats located on tree trunks or rocks, even a small canopy opening or selective logging can impact the local surroundings and create less available substrates for future recolonization. Illegal, uncontrolled collection for local medicinal use or for sale in the gardening trade also contributes to the decline of this species in the local area. In conjunction with slow natural recruitment, very specific mycorrhizal requirements for seed germination, and low seedling survival, the population does not have the resiliency to handle continued pressure associated with use³⁵.

Climate change adds additional stressors: changes in rainfall patterns, drought frequency, and phenology will reduce reproductive success and or disrupt pollinator communities. Fragmented populations reduce genetic exchange and increase inbreeding risk, thus lowering adaptive potential. Finally, informational gaps—lack of population data, unclear IUCN status of species in many areas, and limited funding for long-term research—complicate directed conservation actions, planning, and recovery efforts³⁶.

Despite this, micro-propagation is no panacea either: tissue-cultured plants frequently become estranged from the mycorrhizal relationships and environmental conditioning that help plants establish in natural habitats and eventually the wild. Reintroduction plans must therefore involve both in-lab propagation and staged acclimatization, inoculation with an adequate mycorrhizal inoculum, appropriate site selection, and ongoing monitoring of the reintroduction³⁷. Additionally, humane community-based conservation complementary to technical propagation efforts, like training growers to cultivate A. papillosa for the medicinal or horticultural market, may limit illegal harvest of A. papillosa or contribute other livelihood alternatives for ex-tractivist communities. Conservation policy must also emphasize preservation of habitat, sustainable harvest quotas (as warranted), and furthering research to identify population status and biology^38,39.

Future Perspectives:

Acampe papillosa has promising potential as an object of conservation and a potential source for novel bioactive compounds. Ethnobotanical reports for related Acampe species, as well as preliminary phytochemical studies of orchids, suggest the genus may produce alkaloids, phenolic compounds, terpenoids, and glycosides that possess antimicrobial, antioxidant, or cytotoxic properties. An investigation focused on the phytochemistry of A. papillosa—applying state-of-the-art metabolomics, bioassay-guided fractionation, and high-resolution analytical approaches—may lead to the isolation of novel secondary metabolites of interest for pharmacology. Such work could enhance drug discovery efforts for infectious diseases, inflammation, and other clinical therapeutic areas in which traditional use implies efficacy.

To transform traditional uses into clinically useful therapies will require robust verification. Phytochemistry identification should be coupled with in vitro standardized bioassays (antimicrobial panels, enzyme inhibition, cytotoxicity screens), mechanistic studies, and subsequent methodologically rigorous preclinical evaluations (absorption, distribution, susception, pharmacokinetics, phase I and II safety and efficacy applications inspired by kulturnal disciplines). It will be important to standardize extracts by a) defining components and marker compounds, b) validating extraction protocols both in terms of method and quality i.e., consistency and development of compound-class specific protocols, before any human studies. This is fundamental. o establish indicators of characteristics from clinical human applicability - bioassays, and c) ratify consistent qualities of extracts by batch. If, and when the possibility of activity is identified, additional research opportunities arise, leading on from phase I or II work. Overall, activities exhibiting some possible value in the product by further work would likely entail ethically constructed clinical trials - about co-research and partnerships with academic or clinical avenues, sponsor previous to human approval by phase II reported findings interventions on pharmacologic/ presumption, and utilize a sharing approach for community offering informed consents obtained relative to the traditional knowledge.

Taken together, these circumstances demonstrate a strong case for applied propagation and ex situ options. Tissue culture and micropropagation meet several conservation concerns at once. In vitro germination of seeds (both asymbiotic and symbiotic with mycorrhizae) and protocorm culture allow for large-scale propagation of genetically diverse planting material without the need to remove large numbers of adults from the environment. With these techniques, somatic embryogenesis and micropropagation from vegetative tissues may result in rapid scheduling of clones for reintroduction, cannulation, restoration plantings, or simply to lessen pressure from wild collecting. Cryopreservation of germplasm (seeds, protocorms, or meristem) would offer the longest-term genetic repository, complementary to seed banking, which is especially valuable in cases with dust-like seeds that cannot (or, again, are difficult to) store.

The sustainable use of A. papillosa will require a balance between conservation and any commercial development. Suggested approaches include: (1) prioritizing cultivation as the main source for the medicinal or ornamental market, especially since micropropagation procedures can be conducted at community nurseries or smallholders that can support markets and create income; (2) developing harvest protocols of limited rotational harvesting of vegetative materials in a sustainable manner but allow reproductive individuals to remain protected; (3) combining in situ conservation with protected areas and habitat corridors, with ex situ collections and reintroduction if in situ habitats are lost; (4) establishing legal and institutional frameworks that ensure customary rights are recognized and equitable benefits sharing occurs resulting from bioprospecting; and (5) enhancing monitoring systems and making certification schemes to incentivize responsible sourcing (e.g., "wild-harvested sustainable" labels).

In summary, a coordinated program that couples rigorous phytochemical and clinical research, with community-engaged propagation and habitat protection, while finding policy-level protections, offers the best path forward to enhance the conservation of Acampe papillosa while developing it in a responsible and sustainable way as a source of new therapeutic agents.

CONCLUSION:

Acampe papillosa is a remarkable orchid species at the intersection of biodiversity conservation and drug discovery. The bioactive secondary metabolites from A. papillosa, particularly phenolics, flavonoids, tannins, and alkaloids, exhibit credible antioxidant, antimicrobial, anti-inflammatory, and likely anticancer properties. This evidence supports the use of A. papillosa in traditional medicine and suggests applicability in modern medicine more generally. However, as natural populations of A. papillosa decline due to land use change, exploitation, and reproductive constraints, the need to generate integrated conservation strategies is even more pressing. Conservation strategies may rely on a suite of methods: in vitro germination, micropropagation, and cryopreservation combined with local, community-based conservation practices. A future research agenda for A. papillosa should focus on isolating more novel bioactive secondary metabolites, research on their mechanisms and clinical efficacy, and expressing a systematic approach in using standardized formulations. An even more difficult problem will be to reconcile conservation and sustainable use A. papillosa, such that the species remains a valuable medical resource and champion of resilience, thereby supporting biodiversity conservation and drug discovery.

REFERENCES:

1. Kumar A and Singh L, Pharmacognostic study and development of quality control parameters for whole plant of acampe papillosa lindl. Neuro Quantology. 2022; 20(15): 5614-5622. 10.14704/NQ.2022.20.15. NQ88565.

2. Yonzone R, Lama D, and Bhujel RB, Medicinal Orchids of the Himalayan region. East Himalayan Society for Spermatophyte Taxonomy Pleione. 2011; 5(2): 265 – 273.

3. Kumar, S. The Medicinal Plants of North-East India. Scientific Publishers, Jodhpur, India, 2002.

4. Sandeep B. Patil, Nilofar S. Naikwade, Chandrakant S. Magdum, Vikas B. Awale. Some Medicinal Plants Used By People of Sangli District, Maharashtra. Asian J. Pharm. Res. 2011; 1(2): 42-43.

5. Rao, A. N. Medicinal marvels from the mountains of Arunachal Pradesh, Amruth. 2003; 3: 55.

6. Vibha S, Hebbar SS, Mahalakshmi SN, Kekuda PT, A comprehensive review on ethnobotanical applications and pharmacological activities of Acampe praemorsa (Roxb) Blatt and McCann (Orchidaceae). Journal of Drug Delivery and Therapeutics. 2019; 9(1): 331-336.

7. Rittershausen B, and Rittershausen, W. The Practical Encyclopedia of Orchid: A complete guide to orchids and their cultivation (Anness Publication Limited: London) 2002.

8. Joshi, G., L. M. Tewari, N. Lohani, K. Upreti, J. S. Jalal, and G. Tewari. Diversity of orchids in Uttarakhand and their conservation strategy with special reference to their medicinal importance. Rep. Opin. 2009; 1: 47-52.

9. Punita R. Maurya, Swati R. Dhande, Yadunath M. Joshi, Vilasrao J. Kadam. A review on Gmelina arborea Roxb. Research J. Pharmacognosy and Phytochemistry. 2013; 5(2): 69-76.

10. St George I. ‘The Nature Guide to New Zealand Native Orchids’ (Random House New Zealand: Auckland) 1999.

11. St George I (1999) 'The Nature Guide to New Zealand Native Orchids.' (Random House New Zealand: Auckland)

12. Bodford RB. ‘A Guide to Native Australian Orchids’ (Angus and Robertson Ltd: Melbourne) 1969

13. Baral, S. R. and P. P. Khurmi. A Compendium of Medicinal Plants of Nepal. Mass Printing Press, Kathmandu, Nepal, 2006.

14. Vibha S., Hebbar Sushmitha S., Mahalakshmi S.N., Prashith Kekuda T.R. A comprehensive review on ethnobotanical applications and pharmacological activities of Acampe praemorsa (Roxb.) Blatt. and McCann (Orchidaceae), Journal of Drug Delivery and Therapeutics. 2019; 9(1): 331-336. doi:10.22270/jddt. v9i1.2224.

15. Cetzal-lx, W., Basu, S., and Noguera-Savelli, E. (2014). Orchidaceae: The largest Family of Flowering Plants. Retrieved from http://www.eoearth.org/view/article/53725e080cf2aa2ccd8e15.

16. Brummit, R.K., 2001. World geographical scheme for recording plant distributions. 2010.

17. Sonu Jacob, Anil John J., Leena Thomas, Sabulal B.. In vitro pharmacological activity of the whole plant Naregamia alata. Asian J. Research Chem. 2012; 5(2): 265-269.

18. Haq, F. 2012. The ethno botanical uses of medicinal plants of Allai Valley, Western Himalaya Pakistan. Inter. J. Plant Res., 2(1): 21-34, doi: 10.5923/j.plant.20120201.04.

19. Das, P. K., S. Sahoo, and S. Bal. Ethnobotanical studies on orchids of Niyamgiri Hill Ranges, Orissa, India. Ethnobot. Leaflets. 2008; 12: 70-78.

20. Satish Kumar B.N., Gobinda Mohan Behera, Malay Baidya. Pharmacognosy, Phytochemistry and Pharmacology of Annona squamosa Linn - A Review. Research J. Pharmacognosy and Phytochemistry 2011; 3(3): 93-102.

21. Indu Sharma, Bharat Parashar, Hitesh Kumar Dhamija, Ritu sharma. An Ayurvedic Arena for Hypertension Treatment. Asian J. Pharm. Res. 2012; 2(2): 54-58.

22. Goli. Venkateshwarlu, E. Ragyanaik, Kasireddy. Swapna, A. Santhosh, CH. Santhosh. Vitex trifolia -An Important Medicinal Plant: A Review of Its Folklore Medicine and Traditional Uses. Asian J. Pharm.Res. 2014; 4(2): 70-71.

23. Mohammad Shamim Qureshi, A. Venkateshwar Reddy, G. S. Kumar, Lubna Nousheen. Ethnobotanical study on Medicinal Plants used by Traditional Health Practitioners and Villagers of Garhphulghar Gram, Chhattisgarh, India. Asian J. Pharm. Res. 2017; 7(2): 98-105.

24. Mythili, K., C. U. Reddy, D. Chamundeeswari, and P. K. Manna. Determination of total phenol, alkaloid, flavonoid and tannin in different extracts of Calanthe triplicata: Research and reviews. J. Pharma. Phytochem, 2014; 2(2): 40-44.

25. Hossain, M. M. Therapeutic orchids: Traditional uses and recent advances-An overview. Fitoterapia. 201; 82: 102-40. DOI: 10.1016/j.fitote.2010.09.007.

26. Hossain, M. M. Therapeutic orchids: Traditional uses and recent advances-An overview. Fitoterapia. 2011; 82: 102-40.

27. Jalal, J. S., S. P. Kumar, L. Tewari, and Y. P. S. Pangtey. Orchids Uses in Traditional Medicine in India. In: National Seminar in Medicinal Plants of Himalayas, Regional Research Institute, Himalaya, India, 2010.

28. Piri H, Pathak P, and Bhanwra RK, Asymbiotic germination of immature embryos of a medicinally important epiphytic orchid Acampe papillosa (Lindl) Lindl. African Journal of Biotechnology. 2013; 12(2): 162-167.

29. AK Meena, MM Rao, RP Meena, P Panda, Renu. Pharmacological and Phytochemical Evidences for the Plants of Wedelia Genus– A Review. Asian J. Pharm. Res. 2011; 1(1): 7-12.

30. Shrestha, R. Some medicinal orchids of Nepal. In: The Himalayan Plants, can they Save Us? Proc. Nepal-Japan joint symposi um on conservati on and utilizati on of Himalayan medicinal resources (Eds. T. Watanabe, A. Takano, M.S. Bista and H.K. Saiju) pp. 153-56. Society for the Conservation and Development of Himalayan Medicinal Resources (SCDHMR), Nepal, 2000.

31. Goli Venkateshwarlu, Ragya Eslavath, Santhosh Anasuri, Gutha Suma, Kasireddy Swapna, Ramesh.Phyllanthus niruri -An Important Medicinal Plant: A Review of its Folklore Medicine and Traditional Uses. Asian J. Res. Pharm. Sci. 2014; 4(2): 110-111.

32. Chinsamy M, Finnie JF, Van Staden J. Anti-inflammatory, antioxidant, anti-cholinesterase activity and mutagenicity of South African medicinal orchids. South African Journal of Botany. 2014; 91: 88–98. https://doi.org/10.1016/j.sajb.2013.12.004.

33. Kashem A, Hoque M, and Basher T, Neuropharmacological evaluation with phytochemical screening in different parts of Acampe papillosa (Lindl) Lindl on Swiss albino mice. J Pharmacognosy Phytother. 2025; 17(3): 29-35.

34. Chinsamy M, Finnie JF, Van Staden J. Anti-inflammatory, antioxidant, anti-cholinesterase activity and mutagenicity of South African medicinal orchids. South African Journal of Botany. 2014; 91: 88–98. https://doi.org/10.1016/j.sajb.2013.12.004.

35. Nattaa S, Mondolb SA, Palb K, Mandalb S, Sahanab N, Pala R, Panditb GK, Alama BK, Dasc SS, Biswasa SS, Kalaivanan NS, Chemical composition, antioxidant activity and bioactive constituents of six native endangered medicinal orchid species from north-eastern Himalayan region of India. South African Journal of Botany. 2022; 150: 248-259. https://doi.org/10.1016/j.sajb.2022.07.020

36. Swati S. Shete, Ravindra Jadhav, Sunayana Vikhe. A Review on Pharmacognostical and Pharmacological Activity of Ougeinia oojeinensis. Asian Journal of Research in Pharmaceutical Sciences. 2022; 12(1): 17-0.

37. D. Barman and R Devadas. Climate change on orchid population and conservation strategies: A review. Journal of Crop and Weed. 2013; 9(2): 1-12.

38. Kavita R. Chandramore, Rohan S. Ahire. Synthesis of Ethyl 2-(4-halobenzyl)-3-oxobutanoate and determination of its biological activity by using the prediction of activity spectra for substances. Asian Journal of Research in Pharmaceutical Sciences. 2022; 12(2): 102-6.

Received on 27.09.2025 Revised on 20.11.2025

Accepted on 10.01.2026 Published on 31.01.2026

Available online from February 07, 2026

Res. J. Pharmacognosy and Phytochem. 2026; 18(1):106-114.

DOI: 10.52711/0975-4385.2026.00015

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.

Compound Class / Parameter	Specific Compound / Value	Part Analyzed / Extract	Analytical Method	Significance / Potential Activity
Total Phenol Content	4.09 g GAE/100 g	Pseudobulbs and Leaves	Spectrophotometry	Potent antioxidant, anti-inflammatory
Total Tannin Content	3.17 g TAE/100 g	Pseudobulbs and Leaves	Spectrophotometry	Astringent, anti-parasitic, anti-ulcer
Total Saponin Content	7.20 g/100 g	Pseudobulbs and Leaves	Gravimetric	Hemolytic, immunomodulatory
Total Alkaloid Content	10.7 g/100 g	Pseudobulbs and Leaves	Gravimetric	Diverse pharmacological effects
Total Flavonoid Content	17.10 mg QE/100 g	Pseudobulbs and Leaves	Spectrophotometry	Antioxidant, enzyme inhibition
Phenolic Acid	Caffeic Acid (224 mg/kg)	Whole Plant / Methanol	HPLC	Antioxidant, anti-inflammatory
Volatile Compound	Methyl (methylthio) disulfide	Whole Plant / Methanol	GC-MS	Antimicrobial, potential biomarker
Stress Metabolite	Spiro [3.5] nonan-1-one, 5-methyl-, trans	Whole Plant / Methanol	GC-MS	UV-protectant, potential bioactivity
Moisture Content	~10.8%	Whole Plant	Loss on Drying	Indicates stability of dried material
Minerals	Fe, Zn, Cu, Mn, Na, K, Ca	Pseudobulbs and Leaves	AAS/Flame Photometry	Essential cofactors for enzymes and health